By Beth Treffeisen – Northeastern Global News
Aging happens. While the rate may vary from species to species and even person to person, targeting aging may extend the average life expectancy more than prevention or treatment of diseases, according to Northeastern experts.
Researchers and pharmaceutical companies continue to search for treatments for chronic diseases such as cancer, heart disease and diabetes. But while medicine has helped reduce mortality, it doesn’t look at the larger picture of aging.
Aging plays a crucial role in the onset of many diseases that affect the body’s organs.
Preventative measures to treat aging at the molecular level may provide more benefits than reactive therapeutic approaches that target a single disease or organ—which do not extend lifespans, says Ramkumar Hariharan, a senior scientist at the Institute for Experiential AI at Northeastern University.
Click Here to View the Full Article
